Management of myocarditis in clinical practice

被引:8
|
作者
Baritussio, Anna [1 ]
Giordani, Andrea S. [1 ]
Rizzo, Stefania [2 ]
Masiero, Giulia [1 ]
Iliceto, Sabino [1 ]
Marcolongo, Renzo [3 ]
Caforio, Alida L. [1 ]
机构
[1] Univ Padua, Univ Hosp Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Unit Cardiol, Via Giustiniani 2, I-35128 Padua, Italy
[2] Univ Padua, Univ Hosp Padua, Dept Cardiac Thorac & Vasc Sci & Publ Hlth, Unit Cardiovasc Pathol, Padua, Italy
[3] Univ Padua, Univ Hosp Padua, Dept Med, Unit Hematol & Clin Immunol, Padua, Italy
关键词
Myocarditis; Biopsy; Immunosuppression; IMMUNOSUPPRESSIVE THERAPY; STRATIFICATION; DIAGNOSIS;
D O I
10.23736/S2724-5683.21.05732-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myocarditis is an inflammatory heart muscle disease characterized by heterogeneous clinical presentation and outcome. Clinical heterogeneity of myocarditis, ranging from acute onset chest pain with electrocardiographic changes resembling an acute coronary syndrome, to arrhythmic storm and chronic decompensated heart failure, makes diagnosis challenging. However, a correct diagnosis is fundamental to proper patients' management and should always be reeked. Although a definite diagnosis is only provided by endomyocardial biopsy, the European Society of Cardiology task force on myocardial and pericardial diseases provided specific criteria for the diagnosis of clinically suspected myocarditis, which has been facilitated by the advent of noninvasive imaging tests (i.e. cardiovascular magnetic resonance based myocardial tissue characterization). Due to the heterogeneous presentation and disease course of myocarditis, a tailored treatment would be the best strategy, but a standardized management is still not available. However, over the years, new, promising therapies, such as antiviral and immune-suppressive treatment, have come side by side to the standard pharmacological heart treatment, i.e. anti heart failure medications. In this paper we will review the basic principles of myocarditis management in clinical practice, including diagnostic work-up, conventional and disease-specific therapy and patients' follow-up.
引用
收藏
页码:273 / 284
页数:12
相关论文
共 50 条
  • [21] The management of enthesitis in clinical practice
    Koppikar, Sahil
    Eder, Lihi
    CURRENT OPINION IN RHEUMATOLOGY, 2020, 32 (04) : 380 - 386
  • [22] Diabetes management in clinical practice
    Begg, Alan
    PRACTICAL DIABETES, 2014, 31 (08) : 325 - 325
  • [23] Clinical characteristics, diagnosis and management of nivolumab-induced myocarditis
    Li, Meng-Ting
    He, Yang
    Huang, Si-Yong
    Hu, Xiao
    Chen, Ji-Sheng
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (01) : 116 - 126
  • [24] Clinical characteristics, diagnosis and management of nivolumab-induced myocarditis
    Meng-Ting Li
    Yang He
    Si-Yong Huang
    Xiao Hu
    Ji-Sheng Chen
    Investigational New Drugs, 2024, 42 : 116 - 126
  • [25] The management of myocarditis
    Schultheiss, Heinz-Peter
    Kuehl, Uwe
    Cooper, Leslie T.
    EUROPEAN HEART JOURNAL, 2011, 32 (21) : 2616 - U157
  • [26] MYOCARDITIS, A CLINICAL AND PATHOLOGIC STUDY OF 36 CASES OF MYOCARDITIS, WITH SPECIAL REFERENCE TO DIAGNOSTIC CRITERIA AND THERAPEUTIC MANAGEMENT
    LUSTOK, MJ
    CHASE, J
    LUBITZ, JM
    AMERICAN JOURNAL OF MEDICINE, 1951, 10 (04): : 516 - 517
  • [27] THE APPLICABILITY OF RESULTS OF STREAMLINED TRIALS TO CLINICAL-PRACTICE - THE MYOCARDITIS TREATMENT TRIAL
    OCONNELL, JB
    MASON, JW
    STATISTICS IN MEDICINE, 1990, 9 (1-2) : 193 - 197
  • [28] Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management
    Caforio, Alida L. P.
    Marcolongo, Renzo
    Jahns, Roland
    Fu, Michael
    Felix, Stephan B.
    Iliceto, S.
    HEART FAILURE REVIEWS, 2013, 18 (06) : 715 - 732
  • [29] COVID-19 and Myocarditis: Review of Clinical Presentations, Pathogenesis and Management
    Lovell, Jana P.
    Cihakova, Daniela
    Gilotra, Nisha A.
    HEART INTERNATIONAL, 2022, 16 (01): : 20 - 27
  • [30] Myocarditis in the Athlete: Arrhythmogenic Substrates, Clinical Manifestations, Management, and Eligibility Decisions
    Riccardo Vio
    Alessandro Zorzi
    Domenico Corrado
    Journal of Cardiovascular Translational Research, 2020, 13 : 284 - 295